Study Stopped
Study hypothesis was faulty
Transcranial Electrical Stimulation for Mal de Debarquement Syndrome
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this study is to determine whether external neuromodulation using transcranial electrical stimulation (TES) can reduce the perception of self-motion that is experienced by patients with MdDS. Mal de debarquement is translated as the "sickness of disembarkment," and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. A similar form of rocking dizziness can be experienced without a motion trigger in individuals with certain risk factors. Treatment for MdDS is limited and morbidity is high.The goal of the study is to determine whether TES can suppress the rocking dizziness of MdDS either as a standalone therapy or as an adjunctive therapy to other forms of neuromodulation such as transcranial magnetic stimulation. The investigators will determine the optimal treatment duration and stimulation parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 2, 2015
CompletedFirst Posted
Study publicly available on registry
September 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMarch 16, 2023
March 1, 2023
9.3 years
September 2, 2015
March 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dizziness Handicap Inventory
This is a well validated 100 point self-reported scale with Functional, Physical, and Emotional components.
10 years
Secondary Outcomes (2)
Mal de Debarquement Balance Rating Scale
10 years
Hospital Anxiety and Depression Scale
10 years
Other Outcomes (8)
SF-12
10 years
Motion Sickness Susceptibility Scale
10 years
Neo-Five Factor Inventory
10 years
- +5 more other outcomes
Study Arms (2)
Transcranial Electrical Stimulation-Real
EXPERIMENTALThe participant will perform real TES. The forms of TES used in this study will include transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or transcranial random noise stimulation (tRNS). Each stimulation session will last for 20-minutes.
Transcranial Electrical Stimulation-Sham
SHAM COMPARATORThe participant will perform sham TES for 20-minutes. The form of sham TES will depend on the active arm, e.g. if tACS is on the active arm, then the sham tACS will be a different frequency of stimulation. If tDCS is the active arm, then a short ramp up of tDCS followed by a ramp down (about 60-seconds) will be used as the sham arm.
Interventions
A form of external neuromodulation using electrodes on the surface of the head. We will be using the TCT tDCS device (www.trans.cranial.com) or devices constructed by our research group or collaborators.
Eligibility Criteria
You may qualify if:
- Age ≥18 years old
- Willing and capable of interacting with the informed consent process
- Primary disorder being a persistent perception of motion with no other cause determined after a careful interview.
- Able to identity a study buddy and provide contact information
You may not qualify if:
- Subjects who cannot comply with study conditions.
- Active psychiatric condition such as mania or psychosis
- Unstable medical condition
- Implanted metal in the head or neck (metal or shrapnel, deep brain stimulators, aneurysm clips, cochlear stimulators, retinal implants, etc). Dental fillings are acceptable.
- Any active skin disorder that affects skin integrity of the scalp.
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55414, United States
Related Publications (1)
Cha YH, Gleghorn D, Doudican BC. Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de debarquement syndrome. PLoS One. 2022 Feb 4;17(2):e0263558. doi: 10.1371/journal.pone.0263558. eCollection 2022.
PMID: 35120184DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yoon-Hee Cha, MD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2015
First Posted
September 4, 2015
Study Start
September 1, 2013
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
March 16, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
Anonymized data will be shared once recruitment is sufficient to prevent the inadvertent identification of participants by demographic or clinical characteristics